ANTITUMOR ACTIVITY OF PI3K ANTAGONIST AEZS126*IN MODELS OF TRIPLE NEGATIVE BREAST CANCER

被引：0
|
作者：
Engel, J. B. [1 ]
Schmidt, H. [1 ]
Haeussler, S. [1 ]
Diessner, J. [1 ]
Hahne, J. [1 ]
Meyer, S. [1 ]
Wischhusen, J. [1 ]
Dietl, J. [1 ]
Hoenig, A. [1 ]
机构：
[1] Univ Wurzburg, Dept Obstet & Gynecol, Wurzburg, Germany
来源：
ANTICANCER RESEARCH | 2011年 / 31卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1967 / 1968
页数：2
相关论文
共 50 条
  • [21] Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review
    Ricardo L. B. Costa
    Hyo Sook Han
    William J. Gradishar
    Breast Cancer Research and Treatment, 2018, 169 : 397 - 406
  • [22] Antiplatelet drug ticagrelor suppresses triple negative breast cancer metastasis by targeting PI3K
    Wang, Rong
    Jia, Shutao
    Chen, Hongyan
    Luo, Kaitao
    Zhang, Limei
    Song, Yan
    Qing, Chen
    Liu, Dandan
    Zhou, Hongyu
    BIOCHEMICAL PHARMACOLOGY, 2024, 226
  • [23] Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review
    Costa, Ricardo L. B.
    Han, Hyo Sook
    Gradishar, William J.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 169 (03) : 397 - 406
  • [24] MEK and PI3K catalytic activity as predictor of the response to molecularly targeted agents in triple-negative breast cancer
    Sato, Natsuki
    Wakabayashi, Masayuki
    Nakatsuji, Masatoshi
    Kashiwagura, Haruka
    Shimoji, Naohiro
    Sakamoto, Shiho
    Ishida, Atsuko
    Lee, Jangsoon
    Lim, Bora
    Ueno, Naoto T.
    Ishihara, Hideki
    Inui, Takashi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 489 (04) : 484 - 489
  • [25] Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS-126 in models of ovarian cancer
    Hahne, Jens C.
    Kurz, Antje
    Meyer, Susanne R.
    Dietl, Johannes
    Engel, Jorg B.
    Honig, Arnd
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2015, 291 (01) : 131 - 141
  • [26] Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS-126 in models of ovarian cancer
    Jens C. Hahne
    Antje Kurz
    Susanne R. Meyer
    Johannes Dietl
    Jörg B. Engel
    Arnd Honig
    Archives of Gynecology and Obstetrics, 2015, 291 : 131 - 141
  • [27] PI3K Inhibition Sensitizes Patient-derived Tumor Graft Models of Triple Negative Breast Cancer to PARP Inhibition
    Ibrahim, Y.
    Garcia Garcia, C.
    He, L.
    Serra, V.
    Anton, P.
    Guzman, M.
    Cozar, P.
    Ellison, L.
    Scaltriti, M.
    Baslega, J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S251 - S252
  • [28] Efficacy of Mono and Dual PI3K and MAPK Inhibition in Glioblastoma and Triple-Negative Breast Cancer Brain Metastasis Models
    McNeill, Robert
    Van Swearingen, Amanda
    Bash, Ryan
    Azam, Salma
    Canoutas, Demitra
    Constance, Brian
    Schmid, Ralf
    Anders, Carey
    Miller, C.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2014, 73 (06): : 587 - 587
  • [29] Mechanistic basis for PI3K inhibitor antitumor activity and adverse reactions in advanced breast cancer
    Pamela R. Drullinsky
    Sara A. Hurvitz
    Breast Cancer Research and Treatment, 2020, 181 : 233 - 248
  • [30] Mechanistic basis for PI3K inhibitor antitumor activity and adverse reactions in advanced breast cancer
    Drullinsky, Pamela R.
    Hurvitz, Sara A.
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 181 (02) : 233 - 248
12345